Zymeworks Common Stock Stock Price on September 23, 2024

ZYME Stock  USD 12.35  0.45  3.52%   
If you're considering investing in Zymeworks Stock, it is important to understand the factors that can impact its price. As of today, the current price of Zymeworks Common stands at 12.35, as last reported on the 27th of March, with the highest price reaching 12.75 and the lowest price hitting 12.15 during the day. Zymeworks Common Stock shows Sharpe Ratio of -0.064, which attests that the company had a -0.064 % return per unit of risk over the last 3 months. Zymeworks Common Stock exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Zymeworks Common's Standard Deviation of 3.29, mean deviation of 2.57, and Market Risk Adjusted Performance of (0.18) to validate the risk estimate we provide.
  
Zymeworks Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.064

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsZYME

Estimated Market Risk

 3.32
  actual daily
29
71% of assets are more volatile

Expected Return

 -0.21
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.06
  actual daily
0
Most of other assets perform better
Based on monthly moving average Zymeworks Common is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zymeworks Common by adding Zymeworks Common to a well-diversified portfolio.

Related Headline

Syndax Pharmaceuticals Headline on 23rd of September 2024

Filed transaction by Syndax Pharmaceuticals Officer President, Head Of Rd. Grant, award or other acquisition pursuant to Rule 16b-3

Zymeworks Common Valuation on September 23, 2024

It is possible to determine the worth of Zymeworks Common on a given historical date. On September 23, 2024 Zymeworks was worth 13.23 at the beginning of the trading date compared to the closed value of 12.76. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Zymeworks Common stock. Still, in general, we apply an absolute valuation method to find Zymeworks Common's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Zymeworks Common where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Zymeworks Common's related companies.
 Open High Low Close Volume
  13.04    13.23    12.89    13.09    1,576,200  
09/23/2024
  13.23    13.27    12.76    12.76    951,700  
  12.78    12.84    12.47    12.50    456,800  
Backtest Zymeworks Common  |  Zymeworks Common History  |  Zymeworks Common Valuation   PreviousNext  
Open Value
13.23
12.76
Closing Value
23.19
Upside

Zymeworks Common Trading Date Momentum on September 23, 2024

On September 24 2024 Zymeworks Common Stock was traded for  12.50  at the closing time. The top price for the day was 12.84  and the lowest listed price was  12.47 . The trading volume for the day was 456.8 K. The trading history from September 24, 2024 was a factor to the next trading day price decrease. The trading date delta against the next closing price was 2.04% . The trading date delta against the current closing price is 3.21% .

Zymeworks Common Stock Fundamentals Correlations and Trends

By evaluating Zymeworks Common's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Zymeworks Common's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Zymeworks financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Zymeworks Common Stock history

Zymeworks Common investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Zymeworks is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Zymeworks Common Stock will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Zymeworks Common stock prices may prove useful in developing a viable investing in Zymeworks Common
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. Zymeworks Inc. was incorporated in 2003 and is headquartered in Vancouver, Canada. Zymeworks operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 284 people.

Zymeworks Common Stock Technical Analysis

Zymeworks Common technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Zymeworks Common technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Zymeworks Common trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Zymeworks Common Period Price Range

Low
March 27, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Zymeworks Common Stock cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Zymeworks Common March 27, 2025 Market Strength

Market strength indicators help investors to evaluate how Zymeworks Common stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zymeworks Common shares will generate the highest return on investment. By undertsting and applying Zymeworks Common stock market strength indicators, traders can identify Zymeworks Common Stock entry and exit signals to maximize returns

Zymeworks Common Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Zymeworks Common's price direction in advance. Along with the technical and fundamental analysis of Zymeworks Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Zymeworks to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Zymeworks Stock analysis

When running Zymeworks Common's price analysis, check to measure Zymeworks Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zymeworks Common is operating at the current time. Most of Zymeworks Common's value examination focuses on studying past and present price action to predict the probability of Zymeworks Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zymeworks Common's price. Additionally, you may evaluate how the addition of Zymeworks Common to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities